Profil
Jon Aron Olof Heimer is currently the Chief Executive Officer & Director at Olink Proteomics AB and the Chief Executive Officer & Director at Olink Holding AB. He is also the Chairman at Moleculink AB. Previously, he served as the Chief Executive Officer at OxThera AB and the Chairman at Lumina Adhesives AB. He was also the Director of Business Development at Q-Med AB and the Director at Q-linea AB from 2018 to 2019.
Additionally, he has held positions as a Director at Bioimics AB and as a Partner at Nexttobe AB. He completed his undergraduate degree at the University of Uppsala.
Postes actifs de Jon Aron Olof Heimer
| Sociétés | Poste | Début |
|---|---|---|
Moleculink AB
Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Provides diagnostic products for life science research purposes | Président | - |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Provides commercial physical and biological research and development | Directeur Général | 01/01/2016 |
Anciens postes connus de Jon Aron Olof Heimer
| Sociétés | Poste | Fin |
|---|---|---|
| OLIK HLDG | Directeur Général | 01/10/2024 |
| Q-LINEA AB | Président | 01/01/2018 |
Bioimics AB | Directeur/Membre du Conseil | - |
Lumina Adhesives AB
Lumina Adhesives AB Industrial SpecialtiesProcess Industries Provides switchable medical adhesive | Président | - |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
Formation de Jon Aron Olof Heimer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Q-Med AB
Q-Med AB Medical SpecialtiesHealth Technology Develops, manufactures, markets, and sells medical implants for esthetic and medical use | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Moleculink AB
Moleculink AB Electronic Equipment/InstrumentsElectronic Technology Provides diagnostic products for life science research purposes | Electronic Technology |
Q-linea AB
Q-linea AB Medical SpecialtiesHealth Technology Develops procedures, instruments, and systems for protein and nucleic acid analysis | Health Technology |
Lumina Adhesives AB
Lumina Adhesives AB Industrial SpecialtiesProcess Industries Provides switchable medical adhesive | Process Industries |
Nexttobe AB
Nexttobe AB Investment ManagersFinance Acts as an alternative investment manager | Finance |
Bioimics AB | |
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Provides commercial physical and biological research and development | Commercial Services |
Olink Holding AB
Olink Holding AB BiotechnologyHealth Technology Develops proteomics platform | Health Technology |
















